Rani Therapeutics Holdings, Inc. (RANI) vs Seer, Inc. (SEER)
Rani Therapeutics Holdings, Inc. and Seer, Inc. are both Biotechnology companies. Rani Therapeutics Holdings, Inc. and Seer, Inc. are of similar size ($107.3M and $103.6M). Rani Therapeutics Holdings, Inc. grew revenue faster over the last twelve months: 78.7% against −12.7%. Seer, Inc. has the higher net margin (−478.1% vs −597.0%) and the lower return on invested capital (−60.8% vs 0.00%). Across the 16 metrics below, Seer, Inc. leads on 9 and Rani Therapeutics Holdings, Inc. on 7.
Valuation
Profitability
| Metric | RANI | SEER | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 47.70% | 65.16% |
| Operating margin | (652.78%) | (498.19%) | 0.00% |
| Net margin | (596.97%) | (478.05%) | 0.00% |
| Free cash flow margin | (402.83%) | (309.34%) | 0.00% |
| Return on equity | (155.24%) | (26.45%) | (57.72%) |
| Return on assets | (77.54%) | (23.47%) | (49.22%) |
| Return on invested capital | 0.00% | (60.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack